058820.KQ
CMG Pharmaceutical Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 623.00
+7.04%Year over year
Reported trailing growth
- Revenue
- +22.2%
- EBITDA
- -60.6%
- EBIT
- +32.1%
- EPS
- +131.0%
- Free cash flow
- -87.0%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +8.6%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -29.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026